Notably, TRAF2 and TRAF7 demonstrate a significant positive correlation with the chemotherapeutic agents fluorouracil and gemcitabine, which are commonly used in the treatment of pancreatic cancer. Here, TRAF7 is linked to familial pancreatic carcinoma.